Congratulations to Dr Susan Galbraith on being appointed Executive Vice President, Oncology R&D. An outstanding oncologist, Susan has a strong track record of delivering breakthrough science over the past decade at AstraZeneca, resulting in practice-changing new medicines to treat many types of cancer.
Publications
Our innovative science means a strong track-record of publication in peer-reviewed journals, contributing to the foundation of scientific advancement.
We have
160
projects in our pipeline
Corporate Press Release
Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus
Corporate Press Release